Leahy, Wyden Send Letter to DOJ Regarding DEA Enforcement Actions
Recently, the ranking members of the Judiciary and Finance Committees, Senators Patrick Leahy and Ron Wyden, respectively, raised…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Congressional Leaders Question CMS Handling of Medicare Fraud
Leaders of three congressional committees have raised concerns about how the Centers for Medicare and Medicaid Services…
Retaliation, Pre-taliation, and Whistleblower Hotlines: How Compliance…
Handling whistleblowers is one of the biggest challenges facing most compliance officers. Furthermore, recent actions taken by the…
Post-Election Decompression: Where Do We Go from Here?
After almost fifteen months of campaigning, polls, and 24/7 election coverage of “he-said-she-said,” we finally have our answer:…
OIG Releases FY 2017 Work Plan
The United States Health and Human Services (HHS) Office of Inspector General (OIG) recently released its 2017 Work Plan, which…
Tracking Towards a Banner Year for FCPA and FCA Enforcement
There are some strong indicators to suggest that 2016 is on track to be a real banner year regarding Foreign Corrupt Practices Act…
A Win for Patients: Prop 61 in California Rejected
We recently wrote about Proposition 61 in California – a measure that would have required drug makers to provide large discounts…
GSK & China – The Latest FCPA Settlement Isn’t the End
GlaxoSmithKline (“GSK”) reached a settlement with the Chinese government in 2014 related to bribes and improper actions taken by…
FDA Off-Label Hearing: Day One
Yesterday, the Food and Drug Administration (FDA) kicked off a two-day public meeting to review the extent to which off-label…
Is Physician Spending Linked to Malpractice Claims?
A 2015 study is coming back to the forefront with a new interview by Dr. Anupam Jena. Dr. Jena authored the 2015 study, Physician…